Associated Genetic Biomarkers

Overview

NCI Definition: A non-Hodgkin or Hodgkin lymphoma that arises in the brain or spinal cord as a primary lesion. There is no evidence of lymphoma outside the central nervous system at the time of diagnosis. [1]

Central nervous system lymphomas most frequently harbor alterations in MYD88, PIM1, KMT2D, CDKN2A, and TP53 [2].

Most Commonly Altered Genes in Central Nervous System Lymphoma

MYD88 Mutation, MYD88 L265P, MYD88 Exon 5 Mutation, PIM1 Mutation, and KMT2D Mutation are the most common alterations in central nervous system lymphoma [2].

Top Alterations in Central Nervous System Lymphoma

Significant Genes in Central Nervous System Lymphoma

ALK +

BRD3 +

BRD4 +

MYC +

MYCN +

Disease Details

Synonyms
PCNSL, CNS Lymphoma, Malignant Lymphomas of the CNS, Primary Central Nervous System Lymphoma, Malignant Lymphomas of CNS, Primary CNS Lymphoma
Parent(s)
Malignant Central Nervous System Neoplasm
Children
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System, Primary Central Nervous System Lymphoma, Cerebral Lymphoma, and Spinal Cord Lymphoma
OncoTree Name
Malignant Lymphoma
OncoTree Code
MLYM

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.